SK hynix posted record operating profit as Big Tech earnings loom. Six figures show AI’s profits, spending, concentration and uncertain payoff.
The Latest
Six Numbers That Help Frame The AI Boom Before Earnings
A Simple Tool To Flag Scope Creep In Consulting Engagements
A proposed tool would compare client requests with contract scope, track extra work and draft paid-addendum responses. A 30-consultant test is suggested.
Anthropic Expands GSA Partnership To Make Claude Available Across Government
Anthropic says it is widening its GSA partnership to bring Claude to government, but eligibility, terms, safeguards and timing remain unspecified.
Why Is Grok Bot Showing Up At Penn Station?
A headline links Grok with Penn Station and a New York advertising push, but the campaign’s timing, scale and sponsors remain unverified.
6 Best AI Presentation Maker Tools for Faster, Clearer Slides in 2027
Compare six guides to AI presentation tools, from Gamma and Canva to PowerPoint and Copilot, and choose the workflow that fits your needs.
Anthropic Shares Early Progress Using Claude In Drug Development
Anthropic describes early progress using Claude in drug development, but available details provide no methods, results or measured time savings.
GPT-6.1 Sol Helps CodeRabbit Strengthen Security Across Complex Codebases
CodeRabbit says GPT-6.1 Sol helps its security agent examine code changes across repositories, verify selected findings and propose fixes for human review.
What Is The SpaceXAI Class Action Lawsuit About Grok AI?
A Top Class Actions headline says a lawsuit accuses Grok of violating Illinois privacy law, but the plaintiffs, allegations and court status are unconfirmed.
7 Ways FINNY’s Claude Integration Could Support Financial Advisors
FINNY is reported to be bringing campaign results and prospect data to Claude for financial advisors. Availability, workflows and data safeguards remain unclear.
How Anthropic’s Risk List Spans AI Threats From Bioweapons To Blackmail
CNN describes a nearly 100-page Anthropic risk list spanning bioweapons, blackmail and risks to humanity; its contents and status remain unverified here.
